Agnogenic Myeloid Metaplasia
Authors: GEORGE S. NAKAI
Journal: Annals of Internal Medicine (1962)

Article1 September 1962Agnogenic Myeloid MetaplasiaA Survey of Twenty-nine Cases and a Review of the LiteratureGEORGE S. NAKAI, M.D., CHARLES G. CRADDOCK, M.D., F.A.C.P., WILLIAM G. FIGUEROA, M.D.GEORGE S. NAKAI, M.D.Search for more papers by this author, CHARLES G. CRADDOCK, M.D., F.A.C.P.Search for more papers by this author, WILLIAM G. FIGUEROA, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-57-3-419 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAgnogenic myeloid metaplasia is being diagnosed more frequently because of increasing interest and frequent reports in the literature. Opinions have conflicted concerning the etiology of agnogenic myeloid metaplasia and its relationship to the "myeloproliferative disorders." Data on all cases diagnosed as agnogenic myeloid metaplasia at the University of California Medical Center (Los Angeles) and the Wadsworth Veterans Administration Hospital, until June 1960, have been collected in an effort to review all the clinical and pathological findings. In view of the current frequency of the diagnosis, it is necessary to define this disease as accurately as possible, although the etiology remains...References1. WOOD HC: On the relations of leukocythemia and pseudoleukemia. Amer. J. Med. Sci. 63: 373, 1871. CrossrefGoogle Scholar2. HEUCK G: Zwei Fälle von Leukämie mit eigenthümlicken Blut-resp. Knockenmarksbefund. Virchow. Arch. Path. Anat. 78: 475, 1879. CrossrefGoogle Scholar3. OSLER W: On splenic anemia, second paper. Amer. J. Med. Sci. 124: 751, 1902. CrossrefGoogle Scholar4. DONHAUSER JL: The human spleen as a hematoplastic organ, as exemplified in a case of splenomegaly with sclerosis of the bone marrow. J. Exp. Med. 10: 559, 1908. CrossrefMedlineGoogle Scholar5. HICKLING RA: Chronic non-leukemic myelosis. Quart. J. Med. 30: 253, 1937. Google Scholar6. FAVRECROZIERGUICHARD MPA: La myélose aleucémique mégacaryocytaire. Ann. Med. 35: 5, 1934. Google Scholar7. DOWNEYNORDLAND HM: Hematologic and histologic study of a case of myeloid megakaryocytic hepato-splenomegaly. Folia Haemat. 62: 1, 1939. Google Scholar8. VON LAUBEARNETH WJ: Ueber einen Fall von rapid verlaufender schwerer Anämie mit gleichzeitiger leukämischer Beschaffenheit des Blutes. Deut. Arch. Klin. Med. 69: 331, 1901. Google Scholar9. EMILE-WEILCLERC PA: La Splénomégalie chronique avec anémie et réaction myéloïde du sang. Semaine Méd. 22: 373, 1902. Google Scholar10. RATHERY FM: Splénomégalie du type myéloïde sans myélocythémie. Compt. Rend. Soc. Biol. 54: 138, 1902. Google Scholar11. VAQUEZ A: Nature de l'anémie splénique myéloïde. Compt. Rend. Soc. Biol. 56: 792, 1904. Google Scholar12. HIRSHFELD H: Zur Kenntnis der atypischen myeloiden Leukämie. Berl. Klin. Wschr. 42: 1004, 1905. Google Scholar13. HIRSHFELD H: Die generalisierte aleukämische Myelose und ihre Stellung im System der leukämischen Erkrankungen. Z. Klin. Med. 80: 126, 1914. Google Scholar14. VAUGHAN JM: Leuco-erythroblastic anemia. J. Path. Bact. 42: 541, 1936. CrossrefGoogle Scholar15. METTIERRUSK SRGV: Myelofibrosis associated with a leukemoid blood picture. Amer. J. Path. 13: 377, 1937. MedlineGoogle Scholar16. BALLINMORSE MPF: Myelophthisic splenomegaly. J. A. M. A. 539: 1671, 1927. CrossrefGoogle Scholar17. VAUGHAN JM: Myelosclerosis. J. Path. Bact. 42: 541, 1936. CrossrefGoogle Scholar18. CHAPMAN EM: Osteosclerotic anemia. Amer. J. Med. Sci. 185: 181, 1933. CrossrefGoogle Scholar19. HEINER TF: Megakaryocytic myelosis with osteosclerosis. J. Path. Bact. 45: 383, 1937. CrossrefGoogle Scholar20. OSLER W: On splenic anemia. Amer. J. Med. Sci. 119: 54, 1900. CrossrefGoogle Scholar21. JACKSONPARKERLEMON HFHM: Agnogenic myeloid metaplasia of the spleen: a syndrome simulating other more definite hematologic disorders. New Engl. J. Med. 222: 985, 1940. CrossrefGoogle Scholar22. HELLERLEWISOHNPALIN ELMGWE: Aleukemic myelosis. Amer. J. Path. 23: 327, 1947. MedlineGoogle Scholar23. WYATTSOMMERS JPSC: Chronic marrow failure, myelosclerosis, and extramedullary hematopoiesis. Blood 5: 329, 1950. CrossrefMedlineGoogle Scholar24. LEONARDISRAELSWILKINSON BJMCJF: Myelosclerosis. Quart. J. Med. 26: 131, 1957. MedlineGoogle Scholar25. BLOCKJACOBSON MLO: Myeloid metaplasia. J. A. M. A. 143: 1390, 1950. CrossrefMedlineGoogle Scholar26. LINMANBETHELL JWFH: Agnogenic myeloid metaplasia, its natural history and present day management. Amer. J. Med. 22: 107, 1957. CrossrefMedlineGoogle Scholar27. ERFHERBUT LAPA: Primary and secondary myelofibrosis (clinical and pathological study of 13 cases of fibrosis of bone marrow). Ann. Intern. Med. 21: 863, 1944. LinkGoogle Scholar28. CRAILALTNADLER HWHLWH: Myelofibrosis associated with tuberculosis—a report of 4 cases. Blood 3: 1426, 1948. CrossrefMedlineGoogle Scholar29. ROSENTHAL MC: Extramedullary hemopoiesis. Myeloid metaplasia. Bull. New Engl. Med. Center 12: 154, 1950. MedlineGoogle Scholar30. DAMESHEK W: Some speculations on the myeloproliferative syndromes. Blood 6: 372, 1951. CrossrefMedlineGoogle Scholar31. HUTTPINNIGERWETHERLEY-MEIN MSJLG: The myeloproliferative disorders with special reference to myelofibrosis. Blood 8: 295, 1953. CrossrefMedlineGoogle Scholar32. SPICKARD A: Multiple myeloma with myelofibrosis and with polycythemia vera: further evidence of a relationship between the myeloproliferative disorders. Bull. Johns Hopkins Hosp. 107: 234, 1960. Google Scholar33. THOMPSONILLYNE WPCA: Clinical and hematologic picture resulting from bone marrow replacement. Med. Clin. N. Amer. 24: 841, 1940. CrossrefGoogle Scholar34. JORDANSCOTT HEJK: Case of osteosclerosis with extensive extramedullary hemopoiesis and leukemic blood reaction. Arch. Path. 32: 895, 1941. Google Scholar35. ROSENTHALERF NLA: Clinical observations on osteopetrosis and myelofibrosis. Arch. Intern. Med. 71: 793, 1943. CrossrefGoogle Scholar36. ELMLINGERHUFFTOBIASLAWRENCE PJRLCAJH: Iron turnover abnormalities in patients having anemia: serial blood and in vivo tissue studies with Fe59. Acta Haemat. 9: 73, 1953. CrossrefMedlineGoogle Scholar37. BOTHWELLHURTADODONOHUEFINCH THAVDMCA: Erythrokinetics. IV. The plasma iron turnover as a measure of erythropoiesis. Blood 12: 409, 1957. CrossrefMedlineGoogle Scholar38. MCCURDYRATH PRCE: Splenectomy in hemolytic anemia, results predicted by body scanning after injection of Cr51 tagged red cells. New Engl. J. Med. 259: 459, 1958. CrossrefMedlineGoogle Scholar39. JANDLGREENBERGYONEMOTOCASTLE JHMSRHWB: Clinical determination of the sites of red cell sequestration in hemolytic anemias. J. Clin. Invest. 35: 842, 1956. CrossrefMedlineGoogle Scholar40. MOTULSKYCASSERDGIBLETTBROUNFINCH AGFERGOCA: Anemia and the spleen. New Engl. J. Med. 259: 1164, 1215, 1958. CrossrefMedlineGoogle Scholar41. HUGHES JONESSZUR NCL: Determination of the sites of red cell destruction using Cr51 labelled cells. Brit. J. Haemat. 3: 320, 1957. CrossrefMedlineGoogle Scholar42. PEACE RJ: Myelonecrosis, extramedullary myelopoiesis, and leuko-erythroblastosis. Amer. J. Path. 29: 1029, 1953. MedlineGoogle Scholar43. RUEBNER B: Myelosclerosis with serosal myeloid metaplasia and fatal liver involvement. Ann. Intern. Med. 53: 1075, 1960. LinkGoogle Scholar44. Clinicopathological conference. Ascites and myelofibrosis. Amer. J. Med. 31: 124, 1961. CrossrefMedlineGoogle Scholar45. OISHISWISHERSTORMONTSCHWARTZ MSNJMSI: Portal hypertension in myeloid metaplasia. Arch. Surg. 81: 80, 1960. CrossrefMedlineGoogle Scholar46. RIGBYLEAVELL PGBS: Polycythemia vera. Arch. Intern. Med. 106: 622, 1960. CrossrefMedlineGoogle Scholar47. WASSERMAN LR: Polycythemia vera—its course and treatment and relation to myeloid metaplasia and leukemia. Bull. N. Y. Acad. Med. 30: 343, 1954. MedlineGoogle Scholar48. LONGSIMMONSSCHENKEN RSEEJR: Myeloid metaplasia with terminal leukemia. J. A. M. A. 152: 1619, 1953. CrossrefMedlineGoogle Scholar49. VIDEBAEKPOULSEN AH: Myelofibrosis complicated by lymphogenous leukemia. Acta Haemat. 17: 250, 1957. CrossrefMedlineGoogle Scholar50. BEYREDERRIEDER JH: Diagnosis and clinical course of osteomyelosclerosis. Acta Haemat. 16: 299, 1956. CrossrefMedlineGoogle Scholar51. MITUSBERGNAMEDNICOFFDAMESHEK WJLJIBW: Alkaline phosphatase of mature neutrophils in chronic forms of the myeloproliferative syndrome. Amer. J. Clin. Path. 30: 285, 1958. CrossrefMedlineGoogle Scholar52. KOLERSEAMENOSGOODVANBELLINGHEN RDAJEEP: Myeloproliferative diseases. Diagnostic value of the leukocyte alkaline phosphate test. Amer. J. Clin. Path. 30: 285, 1958. MedlineGoogle Scholar53. TANAKAVALENTINEFREDRICKS KRWNRE: Diseases or clinical conditions associated with low leukocyte alkaline phosphatase. New Engl. J. Med. 262: 912, 1960. CrossrefMedlineGoogle Scholar54. KORSTCLATANOFFSCHILLING DRDVRF: On myelofibrosis. Blood 6: 372, 1951. MedlineGoogle Scholar55. GIBLETTCOLEMANPIRZIO-BIROLIDONOHUEMOTULSKYFINCH ERDHGDMAGCA: Erythrokinetics: quantitative measurements of red cell production and destruction in normal subjects and patients with anemia. Blood 11: 291, 1956. CrossrefMedlineGoogle Scholar56. SZURSMITH LMD: Red cell production and destruction in myelosclerosis. Brit. J. Haemat. 7: 147, 1961. CrossrefMedlineGoogle Scholar57. NATHANBERUN DGNI: Studies of the production and life span of erythrocytes in myeloid metaplasia. Blood 14: 668, 1959. CrossrefMedlineGoogle Scholar58. BALDINIFUDENBERGFUKUTAKEDAMESHEK MHHKW: The anemia of the di Guglielmo syndrome. Blood 14: 334, 1959. CrossrefMedlineGoogle Scholar59. GARDNERPRINGLE FHJC: Androgens and erythropoiesis. II. Treatment of myeloid metaplasia. New Engl. J. Med. 264: 103, 1961. CrossrefMedlineGoogle Scholar60. HANFORDSCHNEIDERMACCARTHY RBGFJD: Massive thoracic extramedullary hemopoiesis. New Engl. J. Med. 263: 120, 1960. CrossrefMedlineGoogle Scholar61. MEYERHEINEKE EA: Über Blutbildung in Milz und Leber bei schweren Anämien. Verh. Deutsch. Ges. Path. 9: 224, 1905. Google Scholar62. DOMINICE M: Sur l'histologie de la rate. A l'état normal et pathologique. Arch. Med. Exp. Anat. Path. 13: 1, 1901. Google Scholar63. GULLANDGOODALL LGA: Pernicious anaemia: a histological study of seventeen cases. J. Path. Bact. 10: 125, 1905. CrossrefGoogle Scholar64. OMURAOSOGOE KB: Saponin induced colonization of the bone marrow elements in foreign organs in rabbits. Anat. Rec. 110: 289, 1951. CrossrefMedlineGoogle Scholar65. BRANNAN D: Extramedullary hematopoiesis in anemias. Bull. Johns Hopkins Hosp. 41: 104, 1927. Google Scholar66. KOLER RD: Prognosis in the myelofibrosismyeloid metaplasia syndrome. Clin. Res. Proc. 5: 57, 1957. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Los Angeles, CaliforniaFrom the Department of Medicine, School of Medicine, University of California at Los Angeles, and the Hematology Research Laboratory, Wadsworth Hospital, Veterans Administration Medical Center, Los Angeles, California.This investigation was partially carried out during tenure of a postdoctoral fellowship from the National Cancer Institute, United States Public Health Service.Supported partly by contract H-1069, United States Public Health Service, and partly by grant P-225A, American Cancer Society.Requests for reprints should be addressed to George S. Nakai, M.D., Department of Medicine, School of Medicine, University of California Medical Center, Los Angeles 24, California. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByPortal Hypertension and Myeloproliferative Neoplasms: A Relationship RevealedAcute variceal bleeding in a patient with idiopathic myelofibrosis successfully treated with endoscopic variceal band ligation and chemotherapy: a case reportAcute Variceal Bleed in a Patient with Idiopathic Myelofibrosis Successfully Treated with Endoscopic Variceal Band LigationENDOSCOPIC INJECTION SCLEROTHERAPY FOR ESOPHAGEAL VARICES IN TWO PATIENTS WITH IDIOPATHIC MYELOFIBROSISEndoscopic injection sclerotherapy for esophageal variceal hemorrhage in a patient with idiopathic myelofibrosisPrimary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survivalIdiopathic myelofibrosis — an update with particular reference to clinical aspects and prognosisIdiopathic myelofibrosis: Historical review, diagnosis and managementHepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsyIdiopathic myelofibrosis: A clinical study of 80 patientsIdiopathic myelofibrosis: A reviewPrognostic factors in idiopathic myelofibrosis: A simple scoring system with prognostic significanceMyelofibrosis: A review of clinical and pathologic features and treatmentAscites progressing to an abdominal mass due to extramedullary hematopoiesis in a patient with agnogenic myeloid metaplasia (AMM)Intractable ascites in idiopathic myelofibrosis: Successful treatment by peritoneovenous (LeVeen) shuntingAscites in agnogenic myeloid metaplasia. Association with peritoneal implant of myeloid tissue and therapyBalanced globin synthesis in idiopathic myelofibrosisSplenic Irradiation in Myelofibrosis: Effect on Circulating Myeloid Progenitor CellsIdiopathic myelofibrosis without splenomegalyBone Marrow Fibre Production in Myelofibrosis: a Quantitative StudyResponse to pyridoxine hydrochloride in refractory anemia due to myelofibrosisNature and Incidence of Liver Involvement in Agnogenic Myeloid MetaplasiaDiagnosis and management of myeloproliferative disordersErythroid Hypoplasia in Myelofibrosis: a Feature Associated with Blastic TransformationClinical Course and Survival after Elective Splenectomy in 19 Patients with Primary MyelofibrosisChronic megakaryocytic-granulocytic myelosis ? An electron microscopic study including freeze-fractureLIGHT and ELECTRON MICROSCOPIC STUDIES OF THE BONE MARROW and BLOOD CELLS IN CHRONIC PANMYELOSIS INCLUDING POLYCYTHEMIA VERA and PRIMARY THROMBOCYTHEMIADefinition, Clinical Features and Diagnosis of MyelofibrosisInter-relationship between Polycythaemia Vera, Leukaemia and Myeloid MetaplasiaDie OsteomyelofibroseGlucose-6-Phosphate Dehydrogenase Deficiency and MyelofibrosisBlutBlutDie An�mie bei Osteomyelosklerose. Vergleich zwischen h�matologischen und erythrokinetischen UntersuchungenBibliographyThe myeloproliferative disordersOesophagusvaricen bei MyelofibroseAscites in myeloid metaplasia due to ectopic peritoneal implantationLEUKOCYTE ALKALINE PHOSPHATASE CYTOCHEMISTRY: APPLICATIONS AND METHODSLEUKOCYTE ALKALINE PHOSPHATASE CYTOCHEMISTRY: APPLICATIONS AND METHODSHemodynamic studies of the portal circulation in myeloid metaplasiaComparison of Philadelphia Chromosome-Positive and -Negative Patients with Chronic Myelocytic LeukemiaSTEPHEN KRAUSS, M.D., JOSEPH E. SOKAL, M.D., AVERY A. SANDBERG, M.D.Myelofibrosis with Myeloid Metaplasia in Survivors of the Atomic Bomb in HiroshimaROBERT E. ANDERSON, M.D., TAKASHI HOSHINO, M.D., TSUTOMU YAMAMOTO, M.D.Anti-Aldosterones 1 September 1962Volume 57, Issue 3Page: 419-440KeywordsEtiologyFellowshipsHematology and oncologyHemoglobinHospital medicineMedical servicesMyeloproliferative disordersPhosphatasesResearch laboratories Issue Published: 1 September 1962 PDF DownloadLoading ...